Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reanalysis of Gene Expression Profiles of CD4+ T Cells Treated with HIV-1 Latency Reversal Agents. | Microorganisms | 2020 | 33007800 | PubTator, text mining | PubMed |
| Inositol Polyphosphate-Based Compounds as Inhibitors of Phosphoinositide 3-Kinase-Dependent Signaling. | Int J Mol Sci | 2020 | 33003448 | PubTator, text mining | PubMed |
| Status of kinases in Epstein-Barr virus and Helicobacter pylori Coinfection in gastric Cancer cells. | BMC Cancer | 2020 | 32993565 | PubTator, text mining | PubMed |
| A Review of the Action of Magnesium on Several Processes Involved in the Modulation of Hematopoiesis. | Int J Mol Sci | 2020 | 32992944 | PubTator, text mining | PubMed |
| Expression Analysis of Fyn and Bat3 Signal Transduction Molecules in Patients with Chronic Lymphocytic Leukemia. | Asian Pac J Cancer Prev | 2020 | 32986360 | PubTator, text mining | PubMed |
| Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies. | Front Immunol | 2020 | 32983132 | PubTator, text mining | PubMed |
| Bioinformatic Identification of Neuroblastoma Microenvironment-Associated Biomarkers with Prognostic Value. | J Oncol | 2020 | 32963529 | PubTator, text mining | PubMed |
| Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma. | Cancers (Basel) | 2020 | 32961934 | PubTator, text mining | PubMed |
| How Different Are the Molecular Mechanisms of Nodal and Distant Metastasis in Luminal A Breast Cancer? | Cancers (Basel) | 2020 | 32947901 | PubTator, text mining | PubMed |
| Competing endogenous RNA network analysis for screening inflammation‑related long non‑coding RNAs for acute ischemic stroke. | Mol Med Rep | 2020 | 32945445 | PubTator, text mining | PubMed |
| Refractory periungual stage II mycosis fungoides with novel LMNA-ROS1 fusion. | JAAD Case Rep | 2020 | 32939388 | PubTator, text mining | PubMed |
| GTF2IRD1 overexpression promotes tumor progression and correlates with less CD8+ T cells infiltration in pancreatic cancer. | Biosci Rep | 2020 | 32936232 | PubTator, text mining | PubMed |
| Immunopharmacology and Quantitative Analysis of Tyrosine Kinase Signaling. | Curr Protoc Immunol | 2020 | 32931655 | PubTator, text mining | PubMed |
| Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers. | Theranostics | 2020 | 32929364 | PubTator, text mining | PubMed |
| Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma. | Signal Transduct Target Ther | 2020 | 32929063 | PubTator, text mining | PubMed |
| IRF1-mediated immune cell infiltration is associated with metastasis in colon adenocarcinoma. | Medicine (Baltimore) | 2020 | 32925784 | PubTator, text mining | PubMed |
| Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors. | Explor Target Antitumor Ther | 2020 | 32924028 | PubTator, text mining | PubMed |
| Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma. | Oncoimmunology | 2020 | 32923142 | PubTator, text mining | PubMed |
| Epigenetic Dynamics of the Infant Immune System Reveals a Tumor Necrosis Factor Superfamily Signature in Early Human Life. | Epigenomes | 2020 | 32922965 | PubTator, text mining | PubMed |
| Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial. | Nat Med | 2020 | 32895571 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=60